Nitric oxide modulates interleukin-1β and tumor necrosis factor-α synthesis by alveolar macrophages in pulmonary tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 1, 2000, Pages 192-199

  Kuo, Han Pin ^a   Wang, Chun Hua ^a   Huang, Kuo Shiung ^a   Lin, Horng Chyuan ^a   Yu, Chih Teng ^a   Liu, Chien Yin ^a   Lu, Ling Chuan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCLONAL ANTIBODY; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOREGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG TUBERCULOSIS; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0033978631     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.1.9902113     Document Type: Article

References (42)

1. 1. Law, K., M. Weiden, T. Harkin, K. Tchou-Wong, C. Chi, and W. N. Rom. 1996. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153:799-804.
2. 2. Ellner, J. J., and R. Wallis. 1989. Immunologic aspects of mycobacterial infections. Rev. Infect. Dis. 11 (Suppl. 2):S455-5429.
3. 3. Kaufmann, S. H., and I. E. Flesh. 1988. The role of T-cell-macrophages interactions in tuberculosis. Semin. Immunopathol. 10:337-358.
4. 4. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J. Immunol. 149:541-547.
5. 5. Orme, I. M., A. D. Roberts, J. P. Griffin, and J. S. Abrams. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol 151:518-525.
6. 6. Bermudez, L. E., and L. S. Young. 1988. Tumor necrosis factor alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol 140:3006-3013.
7. 7. Lopez Ramirez, G. M., W. N. Rom, C. Ciotoli, A. Talbot, F. Martinuik, B. Cronstein, and J. Reibman. 1994. Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells. Infect. Immun. 62:2415-2520.
8. 8. Boom, W. H., R. S. Wallis, and K. Chervenak. 1991. Human Mycobacterium tuberculosis reactive CD4+ T cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect. Immun. 59:2737-2743.
9. 9. Lowrie, D. B. 1990. Is macrophage death on the field of battle essential to victory, or a tactical weakness in immunity against tuberculosis? Clin. Exp. Immunol. 80:301-303.
10. 10. Robinson, D. S., S. Ying, I. K. Taylor, A. Wangoo, D. M. Mitchell, A. B. Kay, Q. Hamid, and R. J. Shaw. 1994. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 149:989-993.
11. 11. Moncada, S., and E. A. Higgs. 1991. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21: 361-374.
12. 12. Nicholson, S., M. da G. Bonecini-Almeida, J. R. Lapa e Silva, C. Nathan, Q. W. Xie, R. Mumford, J. R. Weidner, J. Calaycay, J. Geng, and N. Boechat. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293-2302.
13. 13. Wang, C. H., C. Y. Liu, H. C. Lin, C. T. Yu, K. F. Chung, and H. P. Kuo, 1998. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur. Respir. J. 11:809-815.
14. 14. Andrew, P. J., H. Harant, and I. J. Lindley. 1995. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 214:949-956.
15. 15. Kuo, H. P., K. H. Hwang, H. C. Lin, C. H. Wang, and L. C. Lu. 1997. Effect of endogenous nitric oxide on tumour necrosis factor-alpha-induced leukosequestration and IL-8 release in guinea-pigs airways in vivo. Br. J. Pharmacol. 122:103-111.
16. 16. Muller, J. M., H. W. Ziegler-Heitbrock, and P. A. Baeuerle. 1993. Nuclear factor-kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187:233-256.
17. 17. Chandrasekar, B., J. E. Streitman, J. T. Colston, and G. L. Freeman. 1998. Inhibition of nuclear factor kappa B attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. Biochim. Biophys. Acta 1406:91-106.
18. 18. Toossi, Z., B. D. Hamilton, M. H. Phillips, L. E. Averill, J. J. Ellner, and A. Salvekar. 1997. Regulation of nuclear factor-kappa B and its inhibitor I kappa B-alpha/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. J. Immunol. 159:4109-4116.
19. 19. Kuo H. P., and C. T. Yu. 1993. Alveolar macrophage subpopulations in patients with active pulmonary tuberculosis. Chest 104:1773-1778.
20. 20. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
21. 21. Jagannath, C., J. K. Actor, and R. L. Hunter, Jr. 1998. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric Oxide 2:174-186.
22. 22. Schuller-Levis, G. B., W. R. Levis, M. Ammazzalorso, A. Nosrati, and E. Park. 1994. Mycobacterial lipoarabinomannan induces nitric oxide and tumor necrosis factor alpha production in a macrophage cell line: down regulation by taurine chloramine. Infect. Immun. 62:4671-4674.
23. 23. Doi, T., M. Ando, T. Akaike, M. Suga, K. Sato, and H. Maeda. 1993. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect. Immun. 61:1980-1989.
24. 24. Kamijo, R., J. Gerecitano, D. Shapiro, S. J. Green, M. Aguet, J. Le, and J. Vilcek. 1995-6. Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptor. J. Inflamm. 46:23-31.
25. 25. Chan, J., K. Tanaka, D. Carroll, J. Flynn, B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-740.
26. 26. Aston, C., W. N. Rom, A. T. Talbot, and J. Reibman. 1998. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. Am. J. Respir. Crit. Care Med. 157:1943-1950.
27. 27. Yan, L., S. Wang. S. P. Rafferty, R. A. Wesley, and R. L. Danner. 1997. Endogenously produced nitric oxide increases tumor necrosis factor-α production in transfected human U 937 cells. Blood 90:1160-1167.
28. 28. Eigler, A., J. Moeller, and S. Endres. 1995. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J. Immunol. 154:4048-4054.
29. 29. Lander, H. M., P. Sehajpal, D. M. Levine, and A. Novogrodsky. 1993. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1509-1516.
30. 30. Persoons, J. H., K. Schornagel, F. F. Tilders, J. De Vente, F. Berkenbosch, G. Kraal. 1996. Alveolar macrophages autoregulate 1L-1 and IL-6 production by endogenous nitric oxide. Am. J. Respir. Cell Mol. Biol. 14:272-278.
31. 31. Magrinat, G., S. N. Mason, P. J. Shami, and J. B. Weinberg. 1992. Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 80:1880-1884.
32. 32. Eigler, A., B. Sinha, and S. Endres. 1993. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem. Biophys. Res. Commun. 196:494-501.
33. 33. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J. Clin. Invest. 91:2076-2083.
34. 34. Zhang, Y., and W. N. Rom. 1993. Regulation of the interleukin-1β gene by mycobacterial components and lipopolysaccharide is mediated by two NF-IL-6-like motifs. Mol. Cell Biol. 13:3831-3837.
35. 35. Zhang, Y., M. Borser, and W. N. Rom. 1994. Activation of the interleukin-6 gene by Mycobactrium tuberculosis or lipopolysachhride is mediated by NF-1L6 and NF-κB. Proc. Natl. Acad. Sci. U.S.A. 91:2225-2229.
36. 36. Takashima, T., C. Ueta, I. Tsuyuguchi, and S. Kishimoto. 1990. Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect. Immun. 58:3286-3292.
37. 37. Moreno, C., J. Taverne, A. Mehlert, C. A. W. Bate, R. J. Brealey, A. Meager, A. W. Rook, and J. H. L. Playfair. 1989. Lipoarabinomannan from M. tuberculosis induces the production of tumor necrosis factor from human and murine macrophages. Clin. Exp. Immunol 76:240-245.
38. 38. Wallis, R. S., M. Amir-Tahmasseb, and J. J. Ellner. 1990. Induction of interleukin I and tumor necrosis factor by mycobacterial proteins: the monocyte Western blot. Proc. Natl. Acad. Sci. U.S.A. 87:3348-3352.
39. 39. Chatterjee, D., A. D. Roberts, K. Lowell, P. Brennan, and I. M. Orm. 1992. Structural basis for the capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun. 60:1249-1253.
40. 40. Nolan, G. P., S. Ghosh, H. C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and I kappa B inhibition of the cloned p65 ubunit of NF-kappa B, a rel-related polypeptide. Cell 64:961-969.
41. 41. Li, C. C., M. Korner, D. K. Ferris, E. Chen, R. M. Dai, and D. L. Longo. 1994. NF-kappa B/Rel family members are physically associated phosphoproteins. Biochem. J. 303:499-506.
42. 42. Hierholzer, C., B. Harbrecht, J. M. Menezes, J. Kane, J. MacMicking, F. Nathan, B. Peitzman, T. R. Billiar and D. J. Tweardy. 1998. Essential role of induced nitric oxide in the initiation of the inflammatory responses after hemorrhagic shock. J. Exp. Med. 187:917-928.